Impact of Extensively Hydrolyzed Infant Formula on Circulating Lipids During Early Life.

early life extensively hydrolyzed infant formula intestinal permeability lipidome lipidomics metabolomics

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2022
Historique:
received: 21 01 2022
accepted: 11 04 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 11 6 2022
Statut: epublish

Résumé

Current evidence suggests that the composition of infant formula (IF) affects the gut microbiome, intestinal function, and immune responses during infancy. However, the impact of IF on circulating lipid profiles in infants is still poorly understood. The objectives of this study were to (1) investigate how extensively hydrolyzed IF impacts serum lipidome compared to conventional formula and (2) to associate changes in circulatory lipids with gastrointestinal biomarkers including intestinal permeability. In a randomized, double-blind controlled nutritional intervention study ( Concentrations of sphingomyelins were higher in the HF group as compared to the RF group. Triacylglycerols (TGs) containing saturated and monounsaturated fatty acyl chains were found in higher levels in the HF group at 3 months, but downregulated at 9 and 12 months of age. LM ratio was lower in the HF group at 9 months of age. In the RF group, the LM ratio was positively associated with ether-linked lipids. Such an association was, however, not observed in the HF group. Our study suggests that HF intervention changes the circulating lipidome, including those lipids previously found to be associated with progression to islet autoimmunity or overt T1D. [Clinicaltrials.gov], identifier [NCT01735123].

Sections du résumé

Background UNASSIGNED
Current evidence suggests that the composition of infant formula (IF) affects the gut microbiome, intestinal function, and immune responses during infancy. However, the impact of IF on circulating lipid profiles in infants is still poorly understood. The objectives of this study were to (1) investigate how extensively hydrolyzed IF impacts serum lipidome compared to conventional formula and (2) to associate changes in circulatory lipids with gastrointestinal biomarkers including intestinal permeability.
Methods UNASSIGNED
In a randomized, double-blind controlled nutritional intervention study (
Results UNASSIGNED
Concentrations of sphingomyelins were higher in the HF group as compared to the RF group. Triacylglycerols (TGs) containing saturated and monounsaturated fatty acyl chains were found in higher levels in the HF group at 3 months, but downregulated at 9 and 12 months of age. LM ratio was lower in the HF group at 9 months of age. In the RF group, the LM ratio was positively associated with ether-linked lipids. Such an association was, however, not observed in the HF group.
Conclusion UNASSIGNED
Our study suggests that HF intervention changes the circulating lipidome, including those lipids previously found to be associated with progression to islet autoimmunity or overt T1D.
Clinical Trial Registration UNASSIGNED
[Clinicaltrials.gov], identifier [NCT01735123].

Identifiants

pubmed: 35685890
doi: 10.3389/fnut.2022.859627
pmc: PMC9171511
doi:

Banques de données

ClinicalTrials.gov
['NCT01735123']

Types de publication

Journal Article

Langues

eng

Pagination

859627

Informations de copyright

Copyright © 2022 Lamichhane, Siljander, Salonen, Ruohtula, Virtanen, Ilonen, Hyötyläinen, Knip and Orešič.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Diabetologia. 2006 Jul;49(7):1512-21
pubmed: 16596359
eNeuro. 2019 Aug 6;6(4):
pubmed: 31324675
Arch Pediatr Adolesc Med. 2012 Jul 1;166(7):608-14
pubmed: 22393174
Adv Exp Med Biol. 2010;688:1-23
pubmed: 20919643
Tissue Antigens. 2003 Aug;62(2):162-9
pubmed: 12889996
Diabetes Care. 2017 Mar;40(3):398-404
pubmed: 28096222
J Pediatr. 2021 Nov;238:305-311.e3
pubmed: 34293372
Amino Acids. 2016 Mar;48(3):697-705
pubmed: 26497857
Clin Chim Acta. 1990 Feb 28;187(2):79-87
pubmed: 2317938
PLoS One. 2017 Jun 1;12(6):e0177812
pubmed: 28570611
J Lipid Res. 2003 Apr;44(4):754-61
pubmed: 12562829
Methods Mol Biol. 2011;708:247-57
pubmed: 21207295
BMC Bioinformatics. 2010 Jul 23;11:395
pubmed: 20650010
Brain Dev. 2013 Jan;35(1):45-52
pubmed: 22633446
Nat Methods. 2012 Jun 10;9(8):811-4
pubmed: 22688413
Front Pediatr. 2019 Sep 18;7:372
pubmed: 31620408
Clin Transl Gastroenterol. 2019 May 22;10(5):1-10
pubmed: 31082858
Diabetes Metab Res Rev. 2012 Sep;28(6):505-13
pubmed: 22539454
Diabetes Care. 1994 Jan;17(1):13-9
pubmed: 8112184
Eur J Gastroenterol Hepatol. 2002 Jul;14(7):745-52
pubmed: 12169983
N Engl J Med. 2010 Nov 11;363(20):1900-8
pubmed: 21067382
BMC Gastroenterol. 2014 Nov 18;14:189
pubmed: 25407511
Autoimmune Dis. 2014;2014:437231
pubmed: 24688790
Pediatr Res. 2018 Nov;84(5):726-732
pubmed: 30120403
Nat Commun. 2018 Oct 9;9(1):4169
pubmed: 30301893
Cell Host Microbe. 2018 Jul 11;24(1):146-154.e4
pubmed: 30001517
J Dev Orig Health Dis. 2018 Dec;9(6):573-589
pubmed: 29397805
Ann Clin Biochem. 1991 Jul;28 ( Pt 4):401-6
pubmed: 1909850
Endocrinol Diabetes Metab. 2021 Jan 04;4(2):e00213
pubmed: 33855215
Vaccine. 2006 Feb 27;24(9):1254-63
pubmed: 16229929
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):245-50
pubmed: 14681556
J Endocr Soc. 2020 Feb 20;4(2):bvz039
pubmed: 32099951
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD003517
pubmed: 22895934
J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):112-25
pubmed: 19502997
J Exp Med. 2008 Dec 22;205(13):2975-84
pubmed: 19075291
Eur J Nutr. 2021 Sep;60(6):3355-3363
pubmed: 33611616
Eur J Clin Nutr. 2020 Feb;74(2):268-277
pubmed: 31227804
Nutrients. 2020 Jul 13;12(7):
pubmed: 32668684
JAMA. 2018 Jan 2;319(1):38-48
pubmed: 29297078
Front Nutr. 2020 Mar 11;7:17
pubmed: 32219095
BMC Gastroenterol. 2016 May 26;16(1):55
pubmed: 27229864
Curr Nutr Rep. 2019 Sep;8(3):295-306
pubmed: 31203566
J Allergy Clin Immunol Pract. 2013 Jan;1(1):29-36
pubmed: 24229819
Dtsch Arztebl Int. 2016 Jun 24;113(25):435-44
pubmed: 27397020
Future Lipidol. 2007 Apr;2(2):229-237
pubmed: 19194515
Sci Rep. 2018 Jul 13;8(1):10635
pubmed: 30006587
Clin Chim Acta. 2000 Feb 25;292(1-2):41-54
pubmed: 10686275
BMC Microbiol. 2020 Nov 9;20(1):337
pubmed: 33167908
Metabolomics. 2017;13(3):25
pubmed: 28190990
J Dairy Sci. 2019 Jun;102(6):4816-4831
pubmed: 30981495
Diabetes. 2020 Mar;69(3):465-476
pubmed: 32029481

Auteurs

Santosh Lamichhane (S)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.

Heli Siljander (H)

Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Marja Salonen (M)

Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Terhi Ruohtula (T)

Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Suvi M Virtanen (SM)

Health and Well-Being Promotion Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland.
Center for Child Health Research and Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland.

Jorma Ilonen (J)

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.

Tuulia Hyötyläinen (T)

School of Science and Technology, Örebro University, Örebro, Sweden.

Mikael Knip (M)

Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Center for Child Health Research and Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland.
Department of Paediatrics, Tampere University Hospital, Tampere, Finland.

Matej Orešič (M)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
School of Medical Sciences, Örebro University, Örebro, Sweden.

Classifications MeSH